236 related articles for article (PubMed ID: 29151123)
1. A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes.
Stone VM; Hankaniemi MM; Svedin E; Sioofy-Khojine A; Oikarinen S; Hyöty H; Laitinen OH; Hytönen VP; Flodström-Tullberg M
Diabetologia; 2018 Feb; 61(2):476-481. PubMed ID: 29151123
[TBL] [Abstract][Full Text] [Related]
2. A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.
Larsson PG; Lakshmikanth T; Laitinen OH; Utorova R; Jacobson S; Oikarinen M; Domsgen E; Koivunen MR; Chaux P; Devard N; Lecouturier V; Almond J; Knip M; Hyöty H; Flodström-Tullberg M
Diabetologia; 2015 Feb; 58(2):346-54. PubMed ID: 25370797
[TBL] [Abstract][Full Text] [Related]
3. Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect.
Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine AB; Hytönen VP; Hyöty H; Flodström-Tullberg M
Diabetes; 2021 Dec; 70(12):2871-2878. PubMed ID: 34497136
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine.
Hankaniemi MM; Stone VM; Sioofy-Khojine AB; Heinimäki S; Marjomäki V; Hyöty H; Blazevic V; Laitinen OH; Flodström-Tullberg M; Hytönen VP
Vaccine; 2019 Sep; 37(40):5962-5971. PubMed ID: 31471148
[TBL] [Abstract][Full Text] [Related]
5. Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model.
Hankaniemi MM; Laitinen OH; Stone VM; Sioofy-Khojine A; Määttä JAE; Larsson PG; Marjomäki V; Hyöty H; Flodström-Tullberg M; Hytönen VP
Vaccine; 2017 Jun; 35(30):3718-3725. PubMed ID: 28579231
[TBL] [Abstract][Full Text] [Related]
6. Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine.
Hankaniemi MM; Stone VM; Andrejeff T; Heinimäki S; Sioofy-Khojine AB; Marjomäki V; Hyöty H; Blazevic V; Flodström-Tullberg M; Hytönen VP; Laitinen OH
Antiviral Res; 2019 Nov; 171():104595. PubMed ID: 31491431
[TBL] [Abstract][Full Text] [Related]
7. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
[TBL] [Abstract][Full Text] [Related]
8. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
Tracy S; Drescher KM; Chapman NM; Kim KS; Carson SD; Pirruccello S; Lane PH; Romero JR; Leser JS
J Virol; 2002 Dec; 76(23):12097-111. PubMed ID: 12414951
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
[TBL] [Abstract][Full Text] [Related]
10. Development of A Neonatal Mouse Model for Coxsackievirus B1 Antiviral Evaluation.
Yin Z; Wu Y; Zhu R; Xu L; Lin Y; Yang H; Fu W; Huang Q; Zhang D; Wang J; Wang W; Wang Y; Cheng T; Xia N
Virol Sin; 2021 Dec; 36(6):1575-1584. PubMed ID: 34581960
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.
McCall KD; Thuma JR; Courreges MC; Benencia F; James CB; Malgor R; Kantake N; Mudd W; Denlinger N; Nolan B; Wen L; Schwartz FL
Endocrinology; 2015 Feb; 156(2):453-61. PubMed ID: 25422874
[TBL] [Abstract][Full Text] [Related]
12. Developing a vaccine for type 1 diabetes by targeting coxsackievirus B.
Hyöty H; Leon F; Knip M
Expert Rev Vaccines; 2018 Dec; 17(12):1071-1083. PubMed ID: 30449209
[TBL] [Abstract][Full Text] [Related]
13. Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes.
Oikarinen S; Tauriainen S; Hober D; Lucas B; Vazeou A; Sioofy-Khojine A; Bozas E; Muir P; Honkanen H; Ilonen J; Knip M; Keskinen P; Saha MT; Huhtala H; Stanway G; Bartsocas C; Ludvigsson J; Taylor K; Hyöty H;
Diabetes; 2014 Feb; 63(2):655-62. PubMed ID: 24009257
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus B4 and type 1 diabetes pathogenesis: contribution of animal models.
Jaïdane H; Sané F; Gharbi J; Aouni M; Romond MB; Hober D
Diabetes Metab Res Rev; 2009 Oct; 25(7):591-603. PubMed ID: 19621354
[TBL] [Abstract][Full Text] [Related]
15. Mouse Models of Virus-Induced Type 1 Diabetes.
Christoffersson G; Flodström-Tullberg M
Methods Mol Biol; 2020; 2128():93-105. PubMed ID: 32180188
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.
Tracy S; Drescher KM
Ann N Y Acad Sci; 2007 Apr; 1103():143-51. PubMed ID: 17376828
[TBL] [Abstract][Full Text] [Related]
17. Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice.
Larsson PG; Lakshmikanth T; Svedin E; King C; Flodström-Tullberg M
Diabetologia; 2013 Apr; 56(4):867-74. PubMed ID: 23344730
[TBL] [Abstract][Full Text] [Related]
18. [A bivalent VP1 gene vaccine against Coxsackie virus B1/B3].
Wu X; Zhao T; Tian Y
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):480-4. PubMed ID: 11798923
[TBL] [Abstract][Full Text] [Related]
19. Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.
Kanno T; Kim K; Kono K; Drescher KM; Chapman NM; Tracy S
J Virol; 2006 Jun; 80(11):5637-43. PubMed ID: 16699045
[TBL] [Abstract][Full Text] [Related]
20. Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice.
Davydova B; Härkönen T; Kaialainen S; Hovi T; Vaarala O; Roivainen M
J Med Virol; 2003 Apr; 69(4):510-20. PubMed ID: 12601759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
